CDKN2A and melanoma: Another study identified the CDKN2A gene, which encodes for two cyclin‐dependent kinase inhibitors, p15INK4b and p16INK4a, and a regulator of the p53 pathway and p14ARF, as hypermethylated in a significant number of melanoma cases.106